246 609

Cited 3 times in

Bioresorbable Vascular Scaffold Korean Expert Panel Report

Authors
Ahn, JM | Park, DW | Hong, SJ | Ahn, YK | Hahn, JY | Kim, WJ | Hong, SJ | Nam, CW | Kang, DY | Lee, SY | Chun, WJ | Heo, JH | Cho, DK | Kim, JW | Her, SH | Kim, SW | Yoo, SY | Hong, MK | Tahk, SJ  | Kim, KS | Kim, MH | Jang, Y | Park, SJ
Citation
Korean circulation journal, 47(6). : 795-810, 2017
Journal Title
Korean circulation journal
ISSN
1738-55201738-5555
Abstract
Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.
Keywords
DOI
10.4070/kcj.2017.0300
PMID
29171214
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Cardiology
Ajou Authors
탁, 승제
Full Text Link
Files in This Item:
29171214.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse